Cardiac Genetic Risk testing is informative and useful for the clinical management of various inherited cardiovascular diseases
such as cardiomyopathies, arrhythmic disorders, thoracic aortic aneurysms and dissections, and familial hypercholesterolemia (FH).
Next-generation sequencing (NGS) panels for cardiovascular genomics provide broad coverage of cardiac genes with known disease implications.